Champions Oncology Inc reports results for the quarter ended in January - Earnings Summary

Champions Oncology

16/03/2022 02:45

* Champions Oncology Inc  CSBR.OQ  reported quarterly
adjusted
earnings of 5 cents​​ per share for the quarter ended in
January. The mean expectation of three analysts for the quarter
was for earnings of 3 cents per share.
    * Revenue rose 22% to $13.19 million from a year ago; 
analysts
expected $12.47 million. 
    * Champions Oncology Inc's reported EPS for the quarter was
5
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Champions Oncology Inc shares had fallen by 4.9% this
quarter.
    * The company reported quarterly net income of $787
thousand.
    * Wall Street's median 12-month price target for Champions
Oncology Inc is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 16 at 02:45 a.m.  ​All
figures in US dollars unless otherwise stated